Frank Morgan analyst

Currently out of the existing stock ratings of Frank Morgan, 152 are a BUY (74.51%), 50 are a HOLD (24.51%), 2 are a SELL (0.98%).

Frank Morgan

Work Performance Price Targets & Ratings Chart

Analyst Frank Morgan, currently employed carries an average stock price target met ratio of 75.48% that have a potential upside of 34.45% achieved within 268 days. Previously, Frank Morgan worked at RBC.

Frank Morgan’s has documented 442 price targets and ratings displayed on 30 stocks. The coverage was on Healthcare, Financial Services, Communication Services sectors.

Most recent stock forecast was given on CI, Cigna Corp at 05-Feb-2024.

Wall Street Analyst Frank Morgan

Analyst best performing recommendations are on EHTH (EHEALTH).
The best stock recommendation documented was for SLQT (SELECTQUOTE) at 8/26/2021. The price target of $13 was fulfilled within 14 days with a profit of $5.11 (64.77%) receiving and performance score of 46.26.

Average potential price target upside

ACHC Acadia Healthcare Company ADUS Addus HomeCare AMED Amedisys ANTM Anthem BKD Brookdale Senior Living CHE Chemed Corp CI Cigna Corp CYH Community Health Systems DVA DaVita HealthCare Partners ENSG The Ensign Group FMS Fresenius Medical Care GOCO GoHealth . HCA HCA Holdings HUM Humana LHCG LHC Group MAX MediaAlpha . PNTG Pennant Group SLQT Selectquote THC Tenet Healthcare UHS Universal Health Services UNH UnitedHealth Group orporated BHG Bright Health Group CVS CVS Health Corp EHC Encompass Health Corp EHTH eHealth EVHC Envision Healthcare Holdings SEM Select Medical Holdings AVAH Aveanna Healthcare Holdings ELV Elevance Health SGRY Surgery Partners

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$75

$37.1 (97.89%)

$75

10 days ago
(12-Dec-2024)

9/10 (90%)

$33.08 (78.91%)

95

Hold

$52

$14.1 (37.20%)

$90

12 days ago
(10-Dec-2024)

2/12 (16.67%)

$12.13 (30.42%)

133

Buy

$43

$5.1 (13.46%)

$76

1 months ago
(22-Nov-2024)

2/11 (18.18%)

$4.55 (11.83%)

304

Buy

$64

$26.1 (68.87%)

$94

1 months 4 days ago
(18-Nov-2024)

0/7 (0%)

$27.48 (75.25%)

Buy

$91

$53.1 (140.11%)

$101

7 months 5 days ago
(17-May-2024)

1/4 (25%)

$24.65 (37.15%)

70

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Frank Morgan?

On 2009

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?